A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group

Michael S. Isakoff, Robert Goldsby, Doojduen Villaluna, Mark D. Krailo, Pooja Hingorani, Anderson Collier, Carol D. Morris, E. Anders Kolb, John J. Doski, Richard B. Womer, Richard Gorlick, Katherine A. Janeway

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences